Condition
Amblyopia Unilateral
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07226141Phase 1Recruiting
Valproate for the Treatment of Residual Amblyopia
NCT07622576Not ApplicableNot Yet Recruiting
A Comparative Study of the Efficacy of AR Based Amblyopia Training Therapy and Occlusion Therapy in Older Children and Adults With Amblyopia
NCT06498206Not ApplicableRecruitingPrimary
AR Training Versus Patching in Unilateral Amblyopia
NCT06704737Not ApplicableActive Not RecruitingPrimary
AR Training in Adults With Unilateral Amblyopia
Showing all 4 trials